healthcare
Valneva Shares Tumble After Suspension of US Chikungunya Vaccine Licence
Gaza's Hungry Children Slide Towards Starvation as Emergency Treatments Dwindle
China's Bio-Thera Solutions Licenses Its Arthritis Drug to Germany's Stada
Medtronic Raises Annual Profit Forecast on Lower Tariff Impact
Novo Nordisk Offers Ozempic at $499 per Month to Eligible US Cash-Paying Customers
Date: August 18, 2025
(Reuters) -Novo Nordisk said on Monday that it was launching a new offer for self-paying type 2 diabetes patients to access authentic Ozempic for $499 per month. (Reporting by Sneha S K; Editing by...
FTSE 100 Gains on Healthcare, Defence Rally; Focus on Ukraine Peace Talks
Date: August 18, 2025
(Reuters) -Britain's main stock indexes edged lower on Monday, dragged by losses in financial and energy sector shares, as investors monitor U.S.-led peace negotiations in the Russia-Ukraine conflict....
Shares in Novo Nordisk Rise After Wegovy Gets US Nod for Liver Disease Treatment
Date: August 18, 2025
By Jacob Gronholt-Pedersen COPENHAGEN, DENMARK (Reuters) -Shares in Novo Nordisk rose on Monday, after it got U.S. approval for its weight-loss drug Wegovy to treat a serious liver condition, positive...
Lilly to Hike UK Price of Mounjaro Weight-Loss Drug by 170%
Date: August 14, 2025
LONDON (Reuters) -Eli Lilly will raise the list price in the UK of its weight-loss and type 2 diabetes treatment Mounjaro by 170% to be in line with other European markets, the U.S. drugmaker said on...
UK's Assura Shareholders Back PHP's Bid Over KKR's Cash Offer
Date: August 12, 2025
(Reuters) -Primary Health Properties said on Tuesday it had secured acceptances for 62.9% of Assura shares in its takeover bid for the British healthcare real estate investor. PHP confirmed that all...
Sanofi Stops Supply of High Cholesterol Drug to China Due to Limited Availability
Date: August 12, 2025
SHANGHAI (Reuters) -Sanofi said on Tuesday it had stopped supplying Praluent, a popular cholesterol drug jointly developed by the French pharmaceuticals firm and its partner Regeneron Pharmaceuticals,...